Fluid Films as Models for Understanding the Impact of Inhaled Particles in Lung Surfactant Layers
Source abstract
Abstract
Pollution is currently a public health problem associated with different cardiovascular and respiratory diseases. These are commonly originated as a result of the pollutant transport to the alveolar cavity after their inhalation. Once pollutants enter the alveolar cavity, they are deposited on the lung surfactant (LS) film, altering their mechanical performance which increases the respiratory work and can induce a premature alveolar collapse. Furthermore, the interactions of pollutants with LS can induce the formation of an LS corona decorating the pollutant surface, favoring their penetration into the bloodstream and distribution along different organs. Therefore, it is necessary to understand the most fundamental aspects of the interaction of particulate pollutants with LS to mitigate their effects, and design therapeutic strategies. However, the use of animal models is often invasive, and requires a careful examination of different bioethics aspects. This makes it necessary to design in vitro models mimicking some physico-chemical aspects with relevance for LS performance, which can be done by exploiting the tools provided by the science and technology of interfaces to shed light on the most fundamental physico-chemical bases governing the interaction between LS and particulate matter. This review provides an updated perspective of the use of fluid films of LS models for shedding light on the potential impact of particulate matter in the performance of LS film. It should be noted that even though the used model systems cannot account for some physiological aspects, it is expected that the information contained in this review can contribute on the understanding of the potential toxicological effects of air pollution.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Inhalation and Respiratory Drug Delivery · Neonatal Respiratory Health Research · Air Quality and Health Impacts
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Departamento de Química Física, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Ciudad Universitaria s/n, 28040 Madrid, Spain
Instituto Pluridisciplinar, Universidad Complutense de Madrid, Paseo Juan XXIII 1, 28040 Madrid, Spain
Funding
Ministerio de Ciencia e Innovación · European Commission
References (100+)
Show source-provided references
1. Ecotoxicological and health concerns of persistent coloring pollutants of textile industry wastewater and treatment approaches for environmental safety10.1016/j.jece.2020.105012 ↗
2. WHO (2021, August 16). How Air Pollution Is Destroying Our Health. Available online: https://www.who.int/airpollution/news-and-events/how-air-pollution-is-destroying-our-health.
3. Long-Term Exposure to Air Pollution and Incidence of Cardiovascular Events in Women10.1056/NEJMoa054409 ↗
4. Air Pollution and Cardiovascular Disease10.1161/01.CIR.0000128587.30041.C8 ↗
5. Carbonaceous Particles in the Atmosphere: Experimental and Modelling Issues10.1155/2014/529850 ↗
6. Aili, A., Xu, H., Kasim, T., and Abulikemu, A. (2021). Origin and Transport Pathway of Dust Storm and Its Contribution to Particulate Air Pollution in Northeast Edge of Taklimakan Desert, China. Atmosphere, 12.10.3390/atmos12010113 ↗
7. The Lord of the Lungs: The essential role of pulmonary surfactant upon inhalation of nanoparticles10.1016/j.ejpb.2019.09.020 ↗
8. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy10.1186/1743-8977-2-8 ↗
9. Assessment of atmospheric ultrafine carbon particle-induced human health risk based on surface area dosimetry10.1016/j.atmosenv.2008.08.027 ↗
10. Respirable nano-particulate generations and their pathogenesis in mining workplaces: A review10.1007/s40789-021-00412-w ↗
11. Lung injury caused by occupational exposure to particles from the industrial combustion of cashew nut shells: A mice model10.1080/19338244.2020.1726269 ↗
12. Effects of air pollution on human health and practical measures for prevention in Iran10.4103/1735-1995.189646 ↗
13. Increased Particulate Air Pollution and the Triggering of Myocardial Infarction10.1161/01.CIR.103.23.2810 ↗
14. Liu, S.-T., Liao, C.-Y., Kuo, C.-Y., and Kuo, H.-W. (2017). The Effects of PM2.5 from Asian Dust Storms on Emergency Room Visits for Cardiovascular and Respiratory Diseases. Int. J. Environ. Res. Public Health, 14.10.20944/preprints201703.0142.v1 ↗
15. Urban PM2.5 surface chemistry and interactions with bronchoalveolar lavage fluid10.1080/08958370490443204 ↗
16. Investigation of on-road fine particulate matter exposure concentration and its inhalation dosage levels in an urban area10.1016/j.buildenv.2021.107914 ↗
17. Borghi, F., Spinazzè, A., Mandaglio, S., Fanti, G., Campagnolo, D., Rovelli, S., Keller, M., Cattaneo, A., and Cavallo, D.M. (2021). Estimation of the Inhaled Dose of Pollutants in Different Micro-Environments: A Systematic Review of the Literature. Toxics, 9.10.3390/toxics9060140 ↗
18. Interfacial interaction between benzo[a]pyrene and pulmonary surfactant: Adverse effects on lung health10.1016/j.envpol.2021.117669 ↗
19. Physicochemical Properties of Nanoparticles Regulate Translocation across Pulmonary Surfactant Monolayer and Formation of Lipoprotein Corona10.1021/nn4054683 ↗
20. Effects of binary mixtures of benzo[a]pyrene, arsenic, cadmium, and lead on oxidative stress and toxicity in HepG2 cells10.1016/j.chemosphere.2016.08.137 ↗
21. Health Risk Impacts of Exposure to Airborne Metals and Benzo(a)Pyrene during Episodes of High PM10 Concentrations in Poland
22. Structure-function relationships in pulmonary surfactant membranes: From biophysics to therapy10.1016/j.bbamem.2014.01.028 ↗
23. Assessment of the Pulmonary Toxicity of Inhaled Gases and Particles with Physicochemical Methods10.1080/10803548.1999.11076430 ↗
24. Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films10.1016/j.chemphyslip.2014.09.002 ↗
25. Carrier interactions with the biological barriers of the lung: Advanced in vitro models and challenges for pulmonary drug delivery10.1016/j.addr.2014.05.014 ↗
26. Pulmonary collectins in innate immunity of the lung10.1111/j.1462-5822.2007.00953.x ↗
27. Pulmonary surfactant in health and human lung diseases: State of the art10.1183/09031936.99.13614779 ↗
28. Inhaled aerosols: Their role in COVID-19 transmission, including biophysical interactions in the lungs10.1016/j.cocis.2021.101451 ↗
29. Airborne virus transmission via respiratory droplets: Effects of droplet evaporation and sedimentation10.1016/j.cocis.2021.101471 ↗
30. The COVID-19 pandemic: A target for surfactant therapy?10.1080/17476348.2021.1865809 ↗
31. Airborne Transmission of COVID-19: Aerosol Dispersion, Lung Deposition, and Virus-Receptor Interactions10.1021/acsnano.0c08484 ↗
32. An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function10.1016/j.crtox.2021.05.005 ↗
33. Dynamic dilational properties of composite surfaces10.1016/0166-6622(92)80269-8 ↗
34. Motion of Particles in a Monolayer Induced by Coalescing of a Bubble with a Planar Air-Water Interface10.1021/acs.langmuir.1c00012 ↗
35. Dilational rheology of monolayers of nano- and micropaticles at the liquid-fluid interfaces10.1016/j.cocis.2018.05.001 ↗
36. Tailoring the interfacial assembly of colloidal particles by engineering the mechanical properties of the interface10.1016/j.cocis.2019.02.013 ↗
37. Particle-laden fluid/fluid interfaces: Physico-chemical foundations10.1088/1361-648X/ac0938 ↗
38. Physico-chemical foundations of particle-laden fluid interfaces10.1140/epje/i2018-11708-6 ↗
39. Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade10.2174/0929867327666201005111722 ↗
40. Impact of simulated lung fluid components on the solubility of inhaled drugs and predicted in vivo performance10.1016/j.ijpharm.2021.120893 ↗
41. NanoBioInterface: A multidisciplinary challenge10.1098/rsif.2009.0489.focus ↗
42. Nanoparticle interaction with model lung surfactant monolayers10.1098/rsif.2009.0329.focus ↗
43. Penetration and preferential binding of charged nanoparticles to mixed lipid monolayers: Interplay of lipid packing and charge density10.1039/D0SM01945C ↗
44. Assessment of pollution impact on biological activity and structure of seabed bacterial communities in the Port of Livorno (Italy)10.1016/j.scitotenv.2012.03.033 ↗
45. Qualitative and quantitative analysis of the biophysical interaction of inhaled nanoparticles with pulmonary surfactant by using quartz crystal microbalance with dissipation monitoring10.1016/j.jcis.2019.02.088 ↗
46. Ranking of nanomaterial potency to induce pathway perturbations associated with lung responses10.1016/j.impact.2019.100158 ↗
47. Analysis of Bronchoalveolar Lavage Fluid Adhering to Lung Surfactant-Experiment on Intratracheal Instillation of Nickel Oxide with Different Diameters10.2486/indhealth.MS1253 ↗
48. Fine airborne urban particles (PM2.5) sequester lung surfactant and amino acids from human lung lavage10.1152/ajplung.00131.2007 ↗
49. Design and use of model membranes to study biomolecular interactions using complementary surface-sensitive techniques10.1016/j.cis.2020.102118 ↗
50. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles10.1073/pnas.0608582104 ↗
51. The Evolution of the Protein Corona around Nanoparticles: A Test Study10.1021/nn202458g ↗
52. Time Evolution of the Nanoparticle Protein Corona10.1021/nn901372t ↗
53. Langmuir monolayers as models to study processes at membrane surfaces10.1016/j.cis.2014.02.013 ↗
54. Deactivation of the Pulmonary Surfactant Dynamics by Toxic Aerosols and Gases10.1089/08942680152744668 ↗
55. Low concentrations of negatively charged sub-micron particles alter the microstructure of DPPC at the air–water interface10.1016/j.colsurfa.2012.10.001 ↗
56. Alteration of Surface Properties of Dipalmitoyl Phosphatidylcholine by Benzo[a]pyrene: A Model of Pulmonary Effects of Diesel Exhaust Inhalation10.1166/jbn.2012.1436 ↗
57. Size Influences the Effect of Hydrophobic Nanoparticles on Lung Surfactant Model Systems10.1016/j.bpj.2013.10.036 ↗
58. New experimental model of pulmonary surfactant for biophysical studies10.1016/j.colsurfa.2016.06.044 ↗
59. Lung surfactant-particles at fluid interfaces for toxicity assessments10.1016/j.cocis.2019.01.003 ↗
60. Don’t Forget Langmuir-Blodgett Films 2020: Interfacial Nanoarchitectonics with Molecules, Materials, and Living Objects10.1021/acs.langmuir.0c01044 ↗
61. Physiological fluid interfaces: Functional microenvironments, drug delivery targets, and first line of defense10.1016/j.actbio.2021.05.051 ↗
62. Rubio, R.G., Guzmán, E., Ortega, F., and Liggieri, L. (2021). Monolayers of Cholesterol and Cholesteryl Stearate at the Water/Vapor Interface: A Physico-Chemical Study of Components of the Meibum Layer. Colloids Interfaces, 5.10.3390/colloids5020030 ↗
63. Evaluation of the impact of carbonaceous particles in the mechanical performance of lipid Langmuir monolayers10.1016/j.colsurfa.2021.127974 ↗
64. Guzmán, E., Santini, E., Ferrari, M., Liggieri, L., and Ravera, F. (2022). Evaluating the impact of hydrophobic silicon dioxide in the interfacial properties of lung surfactant films. Environ. Sci. Technol., 56.10.1021/acs.est.1c06885 ↗
65. Effects of nanoparticles on the mechanical functioning of the lung10.1016/j.cis.2015.10.002 ↗
66. Particles on the lung surface—Physicochemical and hydrodynamic effects10.1016/j.cocis.2017.12.003 ↗
67. Interactions of particulate matter and pulmonary surfactant: Implications for human health10.1016/j.cis.2020.102244 ↗
68. Methods and models to investigate the physicochemical functionality of pulmonary surfactant10.1016/j.cocis.2021.101467 ↗
69. Adverse Biophysical Effects of Hydroxyapatite Nanoparticles on Natural Pulmonary Surfactant10.1021/nn2015997 ↗
70. Biophysical Influence of Airborne Carbon Nanomaterials on Natural Pulmonary Surfactant10.1021/acsnano.5b01181 ↗
71. Lung surfactant: Function and composition in the context of development and respiratory physiology10.1016/j.aanat.2016.08.003 ↗
72. Structural hallmarks of lung surfactant: Lipid-protein interactions, membrane structure and future challenges10.1016/j.abb.2021.108850 ↗
73. Dipalmitoylphosphatidylcholine is not the major surfactant phospholipid species in all mammals10.1152/ajpregu.00496.2004 ↗
74. Pulmonary surfactant: Functions and molecular composition10.1016/S0925-4439(98)00060-X ↗
75. Commercial versus Native Surfactants10.1164/ajrccm.162.4.9908104 ↗
76. Specificity and rate of human and mouse liver and plasma phosphatidylcholine synthesis analyzed in vivo10.1194/jlr.D011916 ↗
77. Pulmonary surfactant in birds: Coping with surface tension in a tubular lung10.1152/ajpregu.2001.281.1.R327 ↗
78. Phosphatidylcholine Molecular Species in Lung Surfactant10.1165/ajrcmb.25.6.4616 ↗
79. Pulmonary and gastric surfactants. A comparison of the effect of surface requirements on function and phospholipid composition10.1016/S1095-6433(01)00314-2 ↗
80. Surfactant in newborn compared with adolescent pigs: Adaptation to neonatal respiration10.1165/rcmb.2003-0351OC ↗
81. Cholesterol rules: Direct observation of the coexistence of two fluid phases in native pulmonary surfactant membranes at physiological temperatures10.1074/jbc.M404648200 ↗
82. The pattern of surfactant cholesterol during vertebrate evolution and development: Does ontogeny recapitulate phylogeny?10.1071/RD02087 ↗
83. Recombinant expression of surfactant protein H (SFTA3) in Escherichia coli10.1016/j.aanat.2016.05.006 ↗
84. Surfactant-associated proteins: Functions and structural variation10.1016/S1095-6433(01)00308-7 ↗
85. The physics and physiology of lung surfactants10.1016/S1359-0294(01)00124-8 ↗
86. Pulmonary Surfactant Lipid Reorganization Induced by the Adsorption of the Oligomeric Surfactant Protein B Complex10.1016/j.jmb.2020.02.028 ↗
87. Pulmonary surfactant protein SP-B nanorings induce the multilamellar organization of surfactant complexes10.1016/j.bbamem.2020.183216 ↗
88. Ultrastructure of Lamellar Bodies in Congenital Surfactant Deficiency10.1080/01913120500323480 ↗
89. Interfacial Behavior of Recombinant Forms of Human Pulmonary Surfactant Protein SP-C10.1021/la301134v ↗
90. Effect of Lung Surfactant Protein SP-C and SP-C-Promoted Membrane Fragmentation on Cholesterol Dynamics10.1016/j.bpj.2016.09.016 ↗
91. Divide & Conquer: Surfactant Protein SP-C and Cholesterol Modulate Phase Segregation in Lung Surfactant10.1016/j.bpj.2017.06.059 ↗
92. Structure of pulmonary surfactant membranes and films: The role of proteins and lipid–protein interactions10.1016/j.bbamem.2008.05.003 ↗
93. Structure and phase transitions in Langmuir monolayers10.1103/RevModPhys.71.779 ↗
94. Role of Lipid Polymorphism in Pulmonary Surfactant10.1126/science.273.5273.330 ↗
95. Hydrophobic Surfactant Proteins Induce a Phosphatidylethanolamine to Form Cubic Phases10.1016/j.bpj.2009.12.4302 ↗
96. Differential Effects of the Hydrophobic Surfactant Proteins on the Formation of Inverse Bicontinuous Cubic Phases10.1021/la3025364 ↗
97. An Anionic Phospholipid Enables the Hydrophobic Surfactant Proteins to Alter Spontaneous Curvature10.1016/j.bpj.2012.12.041 ↗
98. A small key unlocks a heavy door: The essential function of the small hydrophobic proteins SP-B and SP-C to trigger adsorption of pulmonary surfactant lamellar bodies10.1016/j.bbamcr.2016.04.028 ↗
99. A model for the structure and mechanism of action of pulmonary surfactant protein B10.1096/fj.15-273458 ↗
100. A combined action of pulmonary surfactant proteins SP-B and SP-C modulates permeability and dynamics of phospholipid membranes10.1042/BJ20110681 ↗